• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The cost of climate change: 2°C global warming target is not economically reasonable unless we make major changes 

Bioengineer by Bioengineer
August 1, 2023
in Health
Reading Time: 2 mins read
0
Climate change cost
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram


Climate change cost

Credit: IOP Publishing


Climate change goals set out in the Paris Agreement are only economically reasonable if non-market factors such as human health and loss of biodiversity are prioritised, according to a new study published by Dr Taikan Oki, former Senior Vice-Rector of United Nations University headquartered in Japan, in IOP Publishing’s academic journal Environmental Research Letters.  

A multi-disciplinary, collaborative effort from researchers at 23 institutions including The University of Tokyo, National Institute for Environmental Studies, and Kyoto University, the new study provides a cost-benefit analysis of climate change including previously neglected non-market factors such as biodiversity loss and the impact on human health. The team calculated the cost of climate change for varying priority systems, estimating the total cost including mitigation between 2010 and 2099 to be 46-230 trillion US dollars.  

The results show that the financial benefits of reducing climate change are often similar to the cost of mitigation efforts. The research team estimate the cost of additional mitigation efforts to be 45 to 130 trillion US dollars, while the financial benefits of these reduction efforts range from 23 to 145 trillion US dollars. They found that for the 2°C temperature goal to be economically feasible there must be a greater emphasis placed on the future impact of biodiversity and health factors, arguing that these factors will become ever more pressing in the future. 

The study shows that climate change would be best approached in an integrated manner with biodiversity and health issues considered side-by-side with economic factors. This is especially true when non-market values are taken into full account including health factors such as diarrhoeal diseases and malaria, and the decrease of species on Earth such as fish and insects.  

Dr Oki, who was formerly the Coordinating Lead Author for the Intergovernmental Panel on Climate Change, says: “The world’s pursuit of climate goals is currently not on track. Our future will depend on how much importance we place on risks such as large-scale irreversible events, as well as how we accept and deal with them. One reason for this is that the costs of mitigation are often similar to, or in excess of, the economic benefits of reducing climate change. We must place a higher priority on non-monetary commodities such as human health and biodiversity and accelerate technological innovations to reduce the mitigation cost.” 



Journal

Environmental Research Letters

DOI

10.1088/1748-9326/accdee

Article Title

Total economic costs of climate change at different discount rates for market and non-market values

Article Publication Date

1-Aug-2023

COI Statement

The authors declare no conflict of interest

Share12Tweet8Share2ShareShareShare2

Related Posts

Adverse Events in Asian Adults on Brivaracetam

September 13, 2025

ARFID hos förskolebarn: En screeningsstudie

September 13, 2025

Insights on Menstrual Health in Eating Disorder Units

September 12, 2025

Nicotine Dependence Linked to Health Behaviors in Korean Smokers

September 12, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Adverse Events in Asian Adults on Brivaracetam

Tumor Microenvironment Dynamics in Breast Cancer Therapy

Extraction Methods Impact Idesia Polycarpa Oil Quality

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.